BAGNOLINI, GRETA
 Distribuzione geografica
Continente #
AS - Asia 1.315
EU - Europa 811
NA - Nord America 638
SA - Sud America 149
AF - Africa 57
OC - Oceania 30
Totale 3.000
Nazione #
US - Stati Uniti d'America 616
CN - Cina 462
IT - Italia 425
SG - Singapore 337
HK - Hong Kong 134
BR - Brasile 126
KR - Corea 104
DE - Germania 102
VN - Vietnam 86
IN - India 74
NL - Olanda 50
GB - Regno Unito 48
FR - Francia 36
JP - Giappone 31
AU - Australia 30
CI - Costa d'Avorio 30
IE - Irlanda 29
SE - Svezia 25
IR - Iran 19
RU - Federazione Russa 18
PK - Pakistan 17
CH - Svizzera 15
TW - Taiwan 13
MX - Messico 12
ES - Italia 11
FI - Finlandia 11
PL - Polonia 11
AR - Argentina 10
CA - Canada 10
AT - Austria 9
BD - Bangladesh 9
TG - Togo 9
TR - Turchia 7
ID - Indonesia 6
ZA - Sudafrica 6
BG - Bulgaria 5
CZ - Repubblica Ceca 4
JO - Giordania 4
PY - Paraguay 4
EG - Egitto 3
IL - Israele 3
MA - Marocco 3
NG - Nigeria 3
BE - Belgio 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
HR - Croazia 2
MY - Malesia 2
PE - Perù 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
LT - Lituania 1
MU - Mauritius 1
MW - Malawi 1
NP - Nepal 1
PH - Filippine 1
Totale 3.000
Città #
Singapore 252
Hefei 199
Ashburn 135
Hong Kong 121
Bologna 120
Seoul 86
Milan 56
Beijing 40
Fairfield 36
Hanoi 32
Abidjan 30
Chandler 29
Dublin 29
Santa Clara 29
Ho Chi Minh City 28
Seattle 26
Tokyo 26
Sydney 25
Houston 23
Falkenstein 22
Dallas 21
Florence 21
Bengaluru 20
Los Angeles 20
Rome 20
Frankfurt am Main 19
Southend 16
Redmond 14
São Paulo 14
Woodbridge 14
Cambridge 13
Munich 13
Jalandhar 12
Jhelum 12
Modena 12
Verona 12
Forlì 11
Genoa 11
Amsterdam 10
Boardman 9
Brooklyn 9
Claymont 9
Lomé 9
Nanjing 9
New York 9
Porto Alegre 9
Redondo Beach 9
Stockholm 9
Boston 8
Buffalo 8
Shanghai 8
Wilmington 8
Chicago 7
Minneapolis 7
Naples 7
Turin 7
Vienna 7
Zurich 7
Berlin 6
Düsseldorf 6
Hyderabad 6
Nijmegen 6
Princeton 6
Tehran 6
Tianjin 6
Athens 5
Barcelona 5
Biên Hòa 5
Denver 5
Haiphong 5
Helsinki 5
Lucca 5
Mexico City 5
Paris 5
Perugia 5
Philadelphia 5
Sofia 5
Taipei 5
Tongling 5
Toronto 5
Amman 4
Brescia 4
Cagliari 4
Carpi 4
Castel Maggiore 4
Des Moines 4
Dongdaemun 4
Geumjeong-gu 4
Hamburg 4
Jakarta 4
Johannesburg 4
Lappeenranta 4
Madrid 4
Monterrey 4
Nuremberg 4
Näfels 4
Olomouc 4
Palm Beach Gardens 4
Piacenza 4
Santaquin 4
Totale 1.981
Nome #
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 237
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 235
Design and synthesis of small molecules targeting pre-miRNA21 toward the development of ribonuclease targeting chimeras (RIBOTACs) to regulate the oncogenic miRNA21 234
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 226
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 222
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives 180
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 172
Inhibition of Urease, a Ni-Enzyme: The Reactivity of a Key Thiol With Mono- and Di-Substituted Catechols Elucidated by Kinetic, Structural, and Theoretical Studies 170
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 136
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 136
Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors to trigger synthetic lethality with Olaparib in pancreatic cancer cells 131
Targeting RNA degradation with small molecules: design and synthesis of selective RNA binders and development of ribonuclease targeting chimeras (RIBOTACs) 127
Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry 125
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 119
Design and synthesis of RAD51-BRCA disruptors to inhibit homologous recombination and achieve synthetic lethality in cancer cells 99
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells 96
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 84
Triggering RNA degradation with small molecules: development of RIBOnuclease TArgeting Chimeras (RIBOTACs) 70
Design and synthesis of small molecules binders of pre-miRNA21 toward the regulation of oncogenic miRNA21 57
DESIGN AND SYNTHESIS OF SMALL MOLECULES TARGETING PRE-MIRNA21 TOWARD THE DEVELOPMENT OF RIBONUCLEASE TARGETING CHIMERAS (RIBOTACS) TO REGULATE THE ONCOGENIC MIRNA21 44
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment 36
Identification of RAD51-BRCA2 inhibitors using N-acylhydrazone-based dynamic combinatorial chemistry 35
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 31
Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA 28
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 24
Totale 3.054
Categoria #
all - tutte 6.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 37 6 0 23 4 5 5
2021/202291 10 4 4 3 5 5 7 14 8 5 12 14
2022/2023142 8 19 7 17 10 9 7 10 21 10 8 16
2023/2024236 11 9 4 7 18 19 21 7 10 18 70 42
2024/2025939 47 33 35 22 85 71 57 21 61 126 132 249
2025/20261.476 301 328 251 332 240 24 0 0 0 0 0 0
Totale 3.054